- Entry
- $120.54
- Final
- $114.57 -5.0%
- Target
- —
- Score
- -0.50
Today BNTX tanked \~20% because SMMT's (down \~40%) results for their drug Ivonescimab wasn't as good as expected. My naive reading is that this BNTX selloff was a knee jerk reaction because they also have a similar drug in the pipeline. However, according to this press release ([https://investors.biontech.de/news-releases/news-release-details/biontech-present-clinical-and-preclinical-data-across-mrna-and](https://investors.biontech.de/news-releases/news-release-details/biontech-present-clinical-and-preclinical-data-across-mrna-and)), BNTX will release results at a conference **THIS WEEKEND** related to that drug **BNT327** They frame these as **HIGHLIGHTS** so I don't think they would be negative. That actually seems great for …
— ORIGINAL POST ·
Short-term BNTX opportunity
· r/wallstreetbets
· Apr 25, 2025